Natus Medical Incorporated (NTUS) Misses Q3 EPS by 1c, Revenues Miss; Q4/FY19 Revenue Guidance Below Consensus, Affirms Q4/FY19 EPS Outlook
Tweet Send to a Friend
Natus Medical Incorporated (NASDAQ: NTUS) reported Q3 EPS of $0.36, $0.01 worse than the analyst estimate of $0.37. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
